C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,887 | -31.8% | 56,391 | +0.9% | 0.00% | – |
| Q2 2023 | $153,753 | -29.5% | 55,910 | -19.5% | 0.00% | – |
| Q1 2023 | $218,101 | +127.8% | 69,459 | +328.1% | 0.00% | – |
| Q4 2022 | $95,733 | -32.6% | 16,226 | -0.2% | 0.00% | – |
| Q3 2022 | $142,000 | +35.2% | 16,256 | +17.3% | 0.00% | – |
| Q2 2022 | $105,000 | -96.9% | 13,855 | -90.0% | 0.00% | -100.0% |
| Q1 2022 | $3,358,000 | -77.5% | 138,412 | -70.2% | 0.00% | -75.0% |
| Q4 2021 | $14,948,000 | -28.9% | 464,202 | -1.3% | 0.00% | -20.0% |
| Q3 2021 | $21,023,000 | +18.4% | 470,523 | +0.2% | 0.01% | +25.0% |
| Q2 2021 | $17,761,000 | -21.2% | 469,395 | -23.0% | 0.00% | -33.3% |
| Q1 2021 | $22,553,000 | +126.5% | 609,719 | +102.9% | 0.01% | +100.0% |
| Q4 2020 | $9,957,000 | – | 300,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |